Is HSDB 8259 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use HSDB 8259? Is HSDB 8259 safe for nursing mother and child? Does HSDB 8259 extracts into breast milk? Does HSDB 8259 has any long term or short term side effects on infants? Can HSDB 8259 influence milk supply or can HSDB 8259 decrease milk supply in lactating mothers?
Answer by DrLact: About HSDB 8259 usage in lactation
No information is available on the clinical use of HSDB 8259 during breastfeeding. Because HSDB 8259 is 97% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during HSDB 8259 therapy and for 2 weeks after the last dose.
Alternate Drugs
Trastuzumab(Unsafe)
Dactinomycin(Dangerous)
Hydroxyurea(Low Risk)
Gemcitabine(Dangerous)
Etoposide(Dangerous)
Nivolumab(Unsafe)
Cladribine(Dangerous)
Ipilimumab(Unsafe)
Doxorubicin(Dangerous)
Vinblastine(Dangerous)
Cetuximab(Unsafe)
Cyclophosphamide(Dangerous)
Bleomycin(Dangerous)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Cisplatin(Unsafe)
Vinorelbine(Dangerous)
Paclitaxel(Dangerous)
Busulfan(Dangerous)
Dacarbazine(Dangerous)
Letrozole(Dangerous)
Azelaic Acid(Safe)
Fluorouracil(Dangerous)
Exemestane(Dangerous)
Alemtuzumab(Low Risk)
Dasatinib(Unsafe)
Rituximab(Low Risk)
Bevacizumab(Low Risk)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Thioguanine(Dangerous)
Vincristine(Dangerous)
Nilotinib(Unsafe)
Tamoxifen(Dangerous)
Docetaxel(Dangerous)
Mitoxantrone(Dangerous)
Mercaptopurine(Safe)
Gemcitabine(Dangerous)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Allopurinol(Safe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)